itm, That's an admirable task, if you could connect the two. Just a suggestion: Try to understand that what the scientific founders and what Prana are doing are not mutually inclusive. The founders have scattered off to other endeavors whose results can be quite different from Prana Biotech's hopes and dreams.
Credit is due to Prana founders in the early days. They can hand-hold Prana for so long, and then it's time for PBT headquarters to follow through as the original founders guided long ago and finally produce something with PBT2. Then they can consider accumulating the wherewithal to go on to other biotech projects such as AD immunology.
Right now all efforts should be with eventually qualifying for Reach2HD Phase III - starting it, working through it without pausing, and concluding it.
itm, That's an admirable task, if you could connect the two....
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $12.53K | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13926044 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 153031722 | 56 |
View Market Depth
| Last trade - 14.56pm 19/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |